[Form 4] FULLER H B CO Insider Trading Activity

Rhea-AI Filing Summary

John J. Corkrean, Executive Vice President and Chief Financial Officer of Fuller H.B. Co. (ticker: FUL), filed a Form 4 reporting a transaction dated 09/12/2025. The filing shows a disposal of 52,196 shares of common stock. The report also lists derivative and equity holdings: 152.89 phantom units (convertible 1-for-1), multiple vested and unvested employee stock options totaling listed shares across exercise prices from $43.48 to $77.72, and restricted stock units totaling 8,991.26 units across several grant dates. Several options are fully vested while others vest in scheduled installments; certain RSUs include dividend equivalents. The form is signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Significant retained equity through multiple employee stock options and restricted stock units indicating ongoing alignment with shareholders
• Some options fully vested, providing liquidity choices that can explain insider dispositions

Negative

• Disposition of 52,196 common shares by the CFO on 09/12/2025 is a notable insider sale reported on Form 4
• Filing does not state the reason for the sale or indicate whether it was made under a Rule 10b5-1 trading plan

Insights

Securities Analyst

TL;DR: Insider sale of 52,196 shares noted alongside substantial option and RSU holdings; transaction warrants routine monitoring.

The Form 4 records a sizable disposition by the CFO on 09/12/2025 while simultaneously documenting extensive equity compensation across option series and restricted stock units. Several options are 100% vested and others follow multi-year vesting schedules; RSUs include dividend equivalent reinvestment. From a market-impact perspective, the filing shows insider liquidity activity but does not disclose proceeds or reason for the sale. The mix of vested options and ongoing unvested awards suggests standard executive compensation realization rather than a corporate event.

Corporate Governance Expert

TL;DR: Executive reported both a significant share disposal and continued material equity alignment via options and RSUs.

The disclosure highlights an insider disposition of 52,196 common shares and retains material holdings via options and RSUs that vest over time, including some fully vested options. The presence of dividend-equivalent features and staged vesting is consistent with retention-focused compensation design. The filing is procedural and compliant in form; it does not include any explanation for the sale or indicate use of a Rule 10b5-1 plan. Absent additional context, governance implications are limited to standard insider trading transparency.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Corkrean John J

(Last) (First) (Middle)

1200 WILLOW LAKE BOULEVARD

P.O. BOX 64683

(Street)

ST. PAUL MN 55164-0683

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FULLER H B CO [ FUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								52,196	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Units	$0.0000(1)	09/12/2025		A		152.89		(2)	(2)	Common Stock	152.89	$61.65	26,609.61(3)	D
Employee Stock Option (Right-to-Buy)	$43.48							05/17/2017(4)	05/17/2026	Common Stock	16,672		16,672	D
Employee Stock Option (Right-to-Buy)	$45.05							01/24/2020(4)	01/24/2029	Common Stock	41,208		41,208	D
Employee Stock Option (Right-to-Buy)	$48.35							01/24/2021(4)	01/24/2030	Common Stock	48,309		48,309	D
Employee Stock Option (Right-to-Buy)	$50.1							01/26/2018(4)	01/26/2027	Common Stock	23,696		23,696	D
Employee Stock Option (Right-to-Buy)	$51.89							01/27/2022(4)	01/27/2031	Common Stock	38,376		38,376	D
Employee Stock Option (Right-to-Buy)	$53.57							01/25/2019(4)	01/25/2028	Common Stock	21,834		21,834	D
Employee Stock Option (Right-to-Buy)	$64.28							01/27/2026(5)	01/27/2035	Common Stock	24,570		24,570	D
Employee Stock Option (Right-to-Buy)	$68.17							01/24/2024(5)	01/24/2033	Common Stock	22,312		22,312	D
Employee Stock Option (Right-to-Buy)	$72.94							01/24/2023(4)	01/24/2032	Common Stock	21,997		21,997	D
Employee Stock Option (Right-to-Buy)	$77.72							01/26/2025(5)	01/26/2034	Common Stock	24,774		24,774	D
Restricted Stock Units	$0.0000(6)							01/24/2024(7)	01/24/2026	Common Stock	1,297.11		1,297.11(8)	D
Restricted Stock Units	$0.0000(6)							01/26/2025(7)	01/26/2027	Common Stock	2,841.16		2,841.16(8)	D
Restricted Stock Units	$0.0000(6)							01/27/2026(7)	01/27/2028	Common Stock	4,352.99		4,352.99(8)	D

Explanation of Responses:

1. These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.

2. These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.

3. Amount includes stock units acquired pursuant to a dividend equivalent feature.

4. This option is 100% vested.

5. This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.

6. These restricted stock units convert into shares of common stock on a 1-for-1 basis.

7. These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.

8. Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.

	/s/ Patrick J. Seul, Attorney-in-Fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did John J. Corkrean report on the Form 4 for FUL?

He reported a disposal of 52,196 common shares on 09/12/2025 and listed multiple derivative and equity holdings including phantom units, stock options, and restricted stock units.

How many phantom units and restricted stock units does the filing show?

152.89 phantom units (convertible 1-for-1) and restricted stock units totaling 8,991.26 units across listed grant dates.

Are any employee stock options fully vested according to the Form 4?

Yes. The filing indicates at least one option (exercise price $43.48, grant 05/17/2017) is 100% vested; other options have scheduled vesting.

Does the Form 4 disclose a trading plan or reason for the sale?

No. The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1 trading plan nor provide a reason for the disposal.

Who signed the Form 4 and when was it filed?

Signed by Patrick J. Seul, Attorney-in-Fact on 09/15/2025 as the filing date reflected in the document.